Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The PIM planners and others have nothing to disclose.

Faculty

Nancy M. Holekamp, MD

Director, Retinal Services
Pepose Vision Institute
Chesterfield, Missouri

Disclosures

Consultant or advisor for: Adverum; Allergan; Annexon; Apellis; Bayer; Cardinal; Clearside Biosciences; EyePoint Pharmaceuticals; Gemini; Genentech; Gyroscope; Katalyst Surgical; Nacuity; NGM; Notal Vision; Novartis; Ocuphire; Outlook Therapeutics; Regeneron; Thea Laboratories; Stealth Biosciences
Speaker or member of speakers bureau for: Allergan; Genentech; Regeneron; Spark
Research funding from: Genentech; Gemini; Gyroscope; Notal Vision
Patent beneficiary of: Katalyst Surgical
Stock options from: Gemini; Nacuity
Owns stock (privately owned) in: Gemini
Owns stock (publicly traded) in: Apellis

Editor

Pakinam Aboulsaoud, PharmD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

Wet Age-Related Macular Degeneration: Presenting Options to Improve Adherence

Authors: Nancy M. Holekamp, MD
CME Released: 4/1/2022
Valid for credit through: 4/1/2023

Start Activity

Credits Available

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

Optometry: This course is COPE approved for 0.25 hours of CE credit.

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for ophthalmologists, optometrists, and primary care providers.

The goal of this activity is that learners will be better able to present alternative forms of medication delivery to patients with age-related macular degeneration (AMD) in an effort to overcome adherence issues and improve quality of life.

Upon completion of this activity, participants will:

Have greater competence related to
- Selection of newer delivery options for anti-vascular endothelial growth factor therapy when treating neovascular age-related macular degeneration (nAMD)
Demonstrate greater confidence in their ability to
- Communicate therapy administration options to patients with nAMD

Disclosures

The PIM planners and others have nothing to disclose.

Faculty

Nancy M. Holekamp, MD

Director, Retinal Services
Pepose Vision Institute
Chesterfield, Missouri

Disclosures

Consultant or advisor for: Adverum; Allergan; Annexon; Apellis; Bayer; Cardinal; Clearside Biosciences; EyePoint Pharmaceuticals; Gemini; Genentech; Gyroscope; Katalyst Surgical; Nacuity; NGM; Notal Vision; Novartis; Ocuphire; Outlook Therapeutics; Regeneron; Thea Laboratories; Stealth Biosciences
Speaker or member of speakers bureau for: Allergan; Genentech; Regeneron; Spark
Research funding from: Genentech; Gemini; Gyroscope; Notal Vision
Patent beneficiary of: Katalyst Surgical
Stock options from: Gemini; Nacuity
Owns stock (privately owned) in: Gemini
Owns stock (publicly traded) in: Apellis

Editor

Pakinam Aboulsaoud, PharmD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

Developed through a partnership between Medscape and Post Graduate Institute for Medicine (PIM).

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Optometrists

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Medscape. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.

Credit Statement: This course is COPE approved for 0.25 hours of CE credit. Activity #123398 and Course ID 76975-TD. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.

Review by

Contact this provider www.pimed.com

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

For Physicians

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

Optometrists

1. Go to www.cmeuniversity.com

2. Login or Create a New Account (will take less than 1 minute)

a. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
b. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page

3. Type in 17064 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter

4. Click on the activity title when it appears

5. Choose the type of credit you desire

6. Complete the online assessment

7. Receive an immediate CME/CE Certificate to download and/or print for your files

From Medscape Education Ophthalmology

CME

Wet Age-Related Macular Degeneration: Presenting Options to Improve Adherence

Authors: Nancy M. Holekamp, MDFaculty and Disclosures

CME Released: 4/1/2022

Valid for credit through: 4/1/2023

processing....

Medscape Clinic Patient Info
Patient first and last name: Tom
Patient Age: 73
Presenting condition: Underwent cataract surgery 14 months ago and was diagnosed with nAMD in his right eye; has been receiving injections of anti-VEGF therapy

Educational Impact Challenge

What did you learn from this activity? Please click on the “Next” button to proceed to a brief survey to see how your knowledge improved after the education. You can also see how your answers compare with those of your peers.

Page 1 of 3

Educational Impact Challenge

CME Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Nancy M. Holekamp, MD

Editor

Pakinam Aboulsaoud, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

CME

Wet Age-Related Macular Degeneration: Presenting Options to Improve Adherence

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Nancy M. Holekamp, MD

Editor

Pakinam Aboulsaoud, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Optometrists

Instructions for Participation and Credit

For Physicians

Optometrists

Wet Age-Related Macular Degeneration: Presenting Options to Improve Adherence

Educational Impact Challenge